Dr Richard Dillon is a Clinical Senior Lecturer in Cancer Genetics in the Department of Medical & Molecular Genetics, School of Basic & Medical Biosciences, at King's College London and Consultant Haematologist at Guy’s Hospital.

Dr Dillon leads a research group focussed on Acute Myeloid Leukaemia (AML). The group uses advanced molecular techniques to refine outcome prediction and personalise treatment for patients with AML. Their work is funded by Blood Cancer UK, Cancer Research UK, Children with Cancer UK and the National Institute for Health Research.